Placing the pet owner and their companions at the center of the entire animal health value chain, how do we design a future where everyone in this ecosystem wins? We’ll discuss…

• The full spectrum of information that helps define prevalence of disease and wellness needs
• Pet owners' need for convenience, transparency and accessibility
• How data unlocks accessibility, affordability, personalization and prediction
• In order for this vision to happen, what are the roadblocks we need to overcome?

Fundraising often reflects progress, it doesn't define it. Michael Rhys (CEO) shares how Barnwell Bio has prioritised producer feedback, early customer validation, and real-world data generation to drive focus, support partnerships, and set the foundation for long-term scale.

Approval alone doesn’t guarantee commercial success. Robert Jordan shares how Vetirus Pharmaceuticals combines in-house regulatory expertise with early manufacturing planning, ensuring supply, shortening timelines to revenue, and enabling global expansion.

The US represents the world's largest and most dynamic animal health market, and we're seeing unprecedented investment and expansion from global leaders.

This panel will explore the strategic rationale behind these major moves: what makes the US market uniquely attractive, how global leaders navigate regulatory complexity and competitive dynamics, and what this wave of international investment signals about where the industry is heading.